CBD patent awarded for treatment of genetic condition: CBD business news in brief

The US Patent and Trademark Office has awarded a specialist pharmaceutical company a patent for a cannabidiol treatment of Fragile X Syndrome – a genetic condition. Other items include news from Australia, Latin America, the EU and the US ...

Restricted content. Do you want to read more?